[Carcinostatic effect of caffeine-8-ether-platinum-complexes].
D000818:Animals; D000970:Antineoplastic Agents / Q000138:chemical synthesis / Q000627:therapeutic use*; D002110:Caffeine / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000627:therapeutic use; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy*; D004353:Drug Evaluation, Preclinical; D051379:Mice; D009944:Organoplatinum Compounds; D010984:Platinum / Q000138:chemical synthesis / Q000627:therapeutic use*; D051381:Rats; D012510:Sarcoma 180 / Q000188:drug therapy; D012517:Sarcoma, Yoshida / Q000188:drug therapy
D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D002110:Caffeine; D010984:Platinum; C033823:cofplaton
Carcinostatische Wirkung eines Coffein-8-äther-Platin-Komplexes.